Agency officials advised healthcare professionals against implanting Equinoxe Shoulder Systems packaged in defective bags.
FDA warns of shoulder implant risks after Exactech declines to start voluntary recall Read More »
Comprimir archivos tiene un montón de ventajas para ti. Algunas de ellas son: liberar espacio en tu memoria USB, en tu disco duro o en tu servicio de almacenamiento en la nube. También te ayuda a reducir el tiempo que tardas en hacer copias de seguridad, restaurar o compartir tus archi …
Compresión de documentos: Optimizando espacio y velocidad Read More »
Chris Barry will become group president of the Medical Solutions Division for 3M’s healthcare business.
The Gates Foundation and some biotechs are betting that the technology could be deployed at scale.
Could Treatments for HIV and Sickle Cell Open the Gene Therapy Floodgates? Read More »
The CEO of Insilico Medicine, which recently became the first company to launch Phase II trials for a drug developed using generative AI, spoke with BioSpace about the rise of the technology.
Insilico CEO Alex Zhavoronkov Discusses AI Drug Discovery Read More »
CNS Pharmaceuticals, Inc. today announced completion of planned enrollment in its global potentially pivotal study evaluating Berubicin.
Cleveland Diagnostics, Inc. announced the closing of over $75M in growth capital financing.
Starlight Therapeutics today announced that Marc Chamberlain, M.D. has joined Starlight as its Chief Medical Officer.
En el vertiginoso avance de la tecnología cuántica, un fenómeno intrigante ha capturado la atención de la comunidad científica: el estado cuántico comprimido. Este concepto revolucionario podría ser la clave para superar las limitaciones actuales en l …
El estado cuántico comprimido: Un avance revolucionario en la computación cuántica Read More »
Ascentage Pharma announced that olverembatinib has been included in the latest guidelines from the National Comprehensive Cancer Network for the management of Chronic Myeloid Leukemia,[1] marking a major development in global recognition for its best-in-class drug candidate, which has been approved in China for the management of tyrosine kinase inhibitor -resistant patients with chronic- and
